PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22981987-8	2012	Half-maximum effect concentrations (IC(50)) for inhibition of Pgp-mediated rhodamine 123 efflux from CCRFvcr1000 cells were 375+-60nM for MC113 versus 8.5+-2.5nM for tariquidar.	Rhodamines	75-84	phosphoglycolate phosphatase	Mus musculus	62-65	
27864369-4	2017	Despite dramatic reduction in rhodamine 123 and calcein-AM transport, the linker-shortened mutant P-gp possesses basal ATPase activity and binds ATP only in its N-terminal nucleotide-binding domain.	Rhodamines	30-39	phosphoglycolate phosphatase	Mus musculus	98-102	
23897419-1	2013	Venlafaxine, and to a lesser extent desvenlafaxine, has previously been shown to induce the expression of the drug efflux transporters P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) in whole cells and alter the cellular permeability of a known drug efflux probe (rhodamine 123).	Rhodamines	282-291	phosphoglycolate phosphatase	Mus musculus	135-149	
23897419-1	2013	Venlafaxine, and to a lesser extent desvenlafaxine, has previously been shown to induce the expression of the drug efflux transporters P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) in whole cells and alter the cellular permeability of a known drug efflux probe (rhodamine 123).	Rhodamines	282-291	phosphoglycolate phosphatase	Mus musculus	151-155	
22525746-6	2012	RESULTS: In rhodamine 123 efflux assay drugs inhibitory potency to P-gp could be ranked quetiapine>N-desmethylclozapine>clozapine>olanzapine.	Rhodamines	12-21	phosphoglycolate phosphatase	Mus musculus	67-71	
22386863-6	2012	The P-glycoprotein (P-gp) function assay in MES-Dx5 cells showed the potential of gelucire-based NPs in inhibiting rhodamine 123 efflux.	Rhodamines	115-124	phosphoglycolate phosphatase	Mus musculus	4-18	
22386863-6	2012	The P-glycoprotein (P-gp) function assay in MES-Dx5 cells showed the potential of gelucire-based NPs in inhibiting rhodamine 123 efflux.	Rhodamines	115-124	phosphoglycolate phosphatase	Mus musculus	20-24	
14502537-7	2003	Rhodamine 123 efflux was reduced by dexloxiglumide from 4.06 (+/-0.34) to 2.84 (+/-0.15) across Caco-2 monolayers, and from 17.3 (+/-0.9) to 8.26 (+/-1.38) across MDR1-MDCK monolayers, further indicating dexloxiglumide interaction with P-gp.	Rhodamines	0-9	phosphoglycolate phosphatase	Mus musculus	236-240	
20230790-4	2010	In vitro, the P-gp antagonist PSC833, a non-calcineurin-inhibitory cyclosporine A analogue, specifically inhibited cellular efflux of the P-gp substrate rhodamine-123 in wild-type CD3(+) T cells and MHC class II(+) APCs but not their P-gp knockout counterparts that lacked rhodamine-123 efflux capacity.	Rhodamines	153-162	phosphoglycolate phosphatase	Mus musculus	14-18	
20230790-4	2010	In vitro, the P-gp antagonist PSC833, a non-calcineurin-inhibitory cyclosporine A analogue, specifically inhibited cellular efflux of the P-gp substrate rhodamine-123 in wild-type CD3(+) T cells and MHC class II(+) APCs but not their P-gp knockout counterparts that lacked rhodamine-123 efflux capacity.	Rhodamines	153-162	phosphoglycolate phosphatase	Mus musculus	138-142	
20230790-4	2010	In vitro, the P-gp antagonist PSC833, a non-calcineurin-inhibitory cyclosporine A analogue, specifically inhibited cellular efflux of the P-gp substrate rhodamine-123 in wild-type CD3(+) T cells and MHC class II(+) APCs but not their P-gp knockout counterparts that lacked rhodamine-123 efflux capacity.	Rhodamines	153-162	phosphoglycolate phosphatase	Mus musculus	138-142	
15458769-9	2004	Moreover, it was found that both celecoxib and diclofenac have the potential to inhibit the function of P-glycoprotein (P-gp) in ECC using rhodamine uptake and efflux assays.	Rhodamines	139-148	phosphoglycolate phosphatase	Mus musculus	104-118	
15458769-9	2004	Moreover, it was found that both celecoxib and diclofenac have the potential to inhibit the function of P-glycoprotein (P-gp) in ECC using rhodamine uptake and efflux assays.	Rhodamines	139-148	phosphoglycolate phosphatase	Mus musculus	120-124	
15934943-8	2005	Tat(1-72)-mediated changes in P-gp expression were correlated with increased rhodamine 123 efflux, indicating the up-regulation of transporter functions of P-gp.	Rhodamines	77-86	phosphoglycolate phosphatase	Mus musculus	30-34	
15934943-8	2005	Tat(1-72)-mediated changes in P-gp expression were correlated with increased rhodamine 123 efflux, indicating the up-regulation of transporter functions of P-gp.	Rhodamines	77-86	phosphoglycolate phosphatase	Mus musculus	156-160	
11212278-8	2001	Accumulation and efflux studies with the P-gp substrates, [3H]daunorubicin and rhodamine 123, demonstrated that XR9576 inhibited P-gp-mediated drug efflux.	Rhodamines	79-88	phosphoglycolate phosphatase	Mus musculus	129-133	
11776553-3	1999	Pgp, a product of mdr1 gene expression, and its function were detected by flow cytometry, immunohistochemistry, and rhodamine test respectively.	Rhodamines	116-125	phosphoglycolate phosphatase	Mus musculus	0-3	
7847840-5	1994	This indicates that the rhodamine efflux is a more function-related marker for MDR than the mdr1 gene and the pgp.	Rhodamines	24-33	phosphoglycolate phosphatase	Mus musculus	110-113